B
BP Portfolio holdings
AUM
$16.9M
1-Year Return
41.46%
This Quarter Return
+14.78%
1 Year Return
+41.46%
3 Year Return
+37.89%
5 Year Return
+61%
10 Year Return
+281.17%
AUM
$2.58B
AUM Growth
+$169M
(+7%)
Cap. Flow
-$133M
Cap. Flow
% of AUM
-5.14%
Top 10 Holdings %
Top 10 Hldgs %
20.48%
Holding
473
New
45
Increased
36
Reduced
58
Closed
91
Top Buys
| 1 |
Baxter International
BAX
|
$8.21M |
| 2 |
Linde
LIN
|
$6.33M |
| 3 |
Analog Devices
ADI
|
$6.32M |
| 4 |
S&P Global
SPGI
|
$5.37M |
| 5 |
3M
MMM
|
$5.19M |
Top Sells
| 1 |
CVS Health
CVS
|
$11.5M |
| 2 |
Cigna
CI
|
$8.08M |
| 3 |
Costco
COST
|
$7.99M |
| 4 |
Union Pacific
UNP
|
$7.69M |
| 5 |
CSX Corp
CSX
|
$7.56M |
Sector Composition
| 1 | Technology | 19.03% |
| 2 | Financials | 14.73% |
| 3 | Healthcare | 14.16% |
| 4 | Communication Services | 10.23% |
| 5 | Consumer Discretionary | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Advance Auto Parts
AAP
$3.63B
| $1.36M | 0.05% |
8,000
| – | – |
|
327
Regency Centers
REG
$13.4B
| $1.35M | 0.05% |
20,000
| – | – |
|
328
Extra Space Storage
EXR
$31.3B
| $1.33M | 0.05% |
13,000
| – | – |
|
329
Coterra Energy
CTRA
$18.3B
| $1.31M | 0.05% |
+50,000
| New | +$1.31M |
|
330
Masco
MAS
$15.9B
| $1.3M | 0.05% |
33,000
| – | – |
|
331
Garmin
GRMN
$45.7B
| $1.3M | 0.05% |
15,000
| – | – |
|
332
International Flavors & Fragrances
IFF
$16.9B
| $1.29M | 0.05% |
10,000
| – | – |
|
333
Jacobs Solutions
J
$17.4B
| $1.28M | 0.05% |
20,552
| – | – |
|
334
Coca-Cola Europacific Partners
CCEP
$40.4B
| $1.24M | 0.05% |
24,000
| – | – |
|
335
Alliant Energy
LNT
$16.6B
| $1.23M | 0.05% |
26,000
| – | – |
|
336
Vistra
VST
$63.7B
| $1.22M | 0.05% |
47,000
| – | – |
|
337
Trimble
TRMB
$19.2B
| $1.21M | 0.05% |
30,000
| – | – |
|
338
Norwegian Cruise Line
NCLH
$11.6B
| $1.21M | 0.05% |
22,000
| – | – |
|
339
Marvell Technology
MRVL
$54.6B
| $1.19M | 0.05% |
60,000
| – | – |
|
|
KSU
340
DELISTED
Kansas City Southern
KSU
| $1.17M | 0.05% |
+10,100
| New | +$1.17M |
|
|
Y
341
DELISTED
Alleghany Corporation
Y
| $1.17M | 0.05% |
1,900
| – | – |
|
342
Albemarle
ALB
$9.6B
| $1.15M | 0.04% |
14,000
| – | – |
|
343
Henry Schein
HSIC
$8.42B
| $1.14M | 0.04% |
19,000
-5,225
| -22% | -$314K |
|
344
Esperion Therapeutics
ESPR
$540M
| $1.13M | 0.04% |
+28,137
| New | +$1.13M |
|
345
W.R. Berkley
WRB
$27.3B
| $1.1M | 0.04% |
43,875
| – | – |
|
346
NOV
NOV
$4.95B
| $1.09M | 0.04% |
+41,000
| New | +$1.09M |
|
347
Halliburton
HAL
$18.8B
| $1.07M | 0.04% |
36,400
-54,600
| -60% | -$1.6M |
|
348
Everest Group
EG
$14.3B
| $1.02M | 0.04% |
4,700
| – | – |
|
349
Allegion
ALLE
$14.8B
| $998K | 0.04% |
11,000
| – | – |
|
350
Quest Diagnostics
DGX
$20.5B
| $980K | 0.04% |
+10,900
| New | +$980K |
|